Article Text
Session III Implications of Alternative Treatment Goals
Panel discussion
Statistics from Altmetric.com
Footnotes
Moderator: John R Hughes
Panellists: John C Ball, Carl C Peck, Stephen I Rennard
↵1 Grudzinskas CV, Wright C. An 18-day approval becomes reality. Pharm Exec 1994: 74-80.